Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,647 | Dovepress* | 14,647+ | 3,383 | 18,030 | |
Totals | 14,647 | 3,383 | 18,030 | ||
*Since 12 April 2010 +Since July 2016 |
View citations on Google Scholar